You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser.
Administrator
Staff member
-
cafead   May 31, 2022 at 10:52: AM
Administrator
Staff member
via Novartis NVS announced that the FDA has approved a label expansion of its CAR-T cell therapy Kymriah (tisagenlecleucel).
article source
<